What C54 covers · when clinicians use it
ICD-10 code C54 identifies Malignant neoplasm of corpus uteri in the U.S. ICD-10-CM clinical and billing record set. It sits within the Neoplasms chapter (C00–D49), the section that groups related diagnoses so providers, payers, and public-health agencies report them consistently. Clinicians and medical coders apply C54 when an encounter's findings match the Malignant neoplasm of corpus uteri description, attaching it to the patient record so downstream insurance claims, payer audits, quality reporting, and epidemiological surveillance all reference the same standardized diagnosis. The ICD-10-CM is maintained by the Centers for Medicare & Medicaid Services and the CDC's National Center for Health Statistics, with an updated official code set released each U.S. fiscal year — always verify C54 against the current CMS/CDC release and your payer's documentation guidance before final use. This page summarizes documentation context for C54 and is a coding reference, not clinical, diagnostic, or billing advice.
C54 refers to Malignant neoplasm of corpus uteri, a group of cancers affecting female reproductive organs and breast tissue. These cancers may be influenced by hormonal, genetic, or infectious factors and often require coordinated gynecologic and oncologic care. ICD10 coding ensures comprehensive clinical documentation and cancer surveillance.
Symptoms
- Lump or mass – Especially in the breast, vulva, or ovary
- Abnormal bleeding – Postmenopausal, between periods, or post-coital
- Pelvic or abdominal pain – May indicate ovarian or uterine cancer
- Vaginal discharge – Unusual color, odor, or quantity
- Breast changes – Dimpling, nipple inversion, or discharge
- Weight loss and fatigue – Common systemic cancer symptoms
- High blood pressure or swelling – In placental neoplasms like choriocarcinoma
Diagnosis
Diagnosis of Malignant neoplasm of corpus uteri involves imaging (mammogram, ultrasound, pelvic MRI), pelvic examination, and biopsy. Pap smears, colposcopy, CA-125 levels, and hormonal or placental markers may assist in specific cancers. Accurate staging and histologic typing are essential for treatment planning.
ICD10 Code Usage
ICD10 code C54 is used to classify gynecologic and breast cancers across healthcare records, insurance claims, pathology reports, and oncology registries. Proper use supports screening programs, treatment pathways, and outcome tracking for women’s health.
Related Codes
- C50 – Malignant neoplasm of breast
- C51 – Malignant neoplasm of vulva
- C52 – Malignant neoplasm of vagina
- C53 – Malignant neoplasm of cervix uteri
- C55 – Malignant neoplasm of uterus, part unspecified
- C56 – Malignant neoplasm of ovary
- C57 – Malignant neoplasm of other and unspecified female genital organs
- C58 – Malignant neoplasm of placenta
FAQs
Q1: What is ICD10 code C54?
A: It refers to Malignant neoplasm of corpus uteri, used in clinical and billing systems to classify female-specific cancers.
Q2: What causes these cancers?
A: Factors include genetic mutations (e.g., BRCA), HPV infection, hormone therapy, or reproductive history.
Q3: Can they be screened?
A: Yes, breast cancer (mammogram), cervical cancer (Pap/HPV tests), and some uterine/ovarian signs can be detected early.
Q4: What are treatment options?
A: Surgery, chemotherapy, radiation, hormone therapy, or immunotherapy depending on cancer type and stage.
Q5: Is pregnancy affected by these cancers?
A: Yes, particularly with placental or cervical cancers. Early diagnosis and multidisciplinary care are critical.
Conclusion
ICD10 code C54 is essential for recording and managing Malignant neoplasm of corpus uteri. It enables accurate diagnosis, supports women’s oncology care, and contributes to public health efforts for cancer prevention and treatment. Proper documentation ensures patient access to care and ongoing research.